Search Results for: BeiGene Initiates Global Phase 3
Articles
January 8, 2018
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody January 8, 2018
BeiGene, Ltd. recently announced that in December 2017, the first patient was dosed in a global Phase 3 clinical trial...
July 6, 2017
BeiGene Initiates Pivotal Trial of PD-1 Antibody July 6, 2017
BeiGene, Ltd. recently announced that the first patient was dosed in a pivotal clinical trial in China of BGB-A317, an...
